Skip to main content

Advertisement

Table 2 Baseline infusion-related characteristics of study devices

From: Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial

Variable 3-Day Routine Change Group (n = 323), n (%) Clinically Indicated Change Group (n = 280), n (%)
IV cannula gauge   
   • 22 43 (13%) 46 (16%)
   • 20 241 (75%) 201 (72%)
   • 18 27 (12%) 30 (11%)
   • Other 2 (1%) 3 (1%)
Vein assessment   
   • Good 143 (44.3%) 107 (38.2%)
   • Fair 160 (49.5%) 144 (51.4%)
   • Poor 20 (6.2%) 29 (10.4%)
Skin integrity   
   • Good 138 (43%) 104 (37%)
   • Fair 178 (55%) 164 (59%)
   • Poor 7 (2%) 12 (4%)
Past history of phlebitis 2 (0.6%) 4 (1.4%)
Insertion site   
   • Hand 206 (64%) 187 (67%)
   • Forearm 59 (18%) 49 (18%)
   • Cubital fossa 51 (16%) 38 (14%)
   • Other 7 (2%) 6 (2%)
Receiving infusate 241 (75%) 215 (77%)
pH of infusate - Mean (SD) 6.0 (0.5) 6.0 (0.4)
Receiving oral antibiotics 24 (7%) 24 (9%)
Receiving IV antibiotics 236 (73%) 176 (63%)
pH of IV antibiotics - Mean (SD) 6.9 (1.1) 6.9 (1.3)
Receiving other IV meds 190 (59%) 179 (64%)
pH of other IV meds - Mean (SD) 5.6 (2.6) 6.0 (2.8)
Wound drain 50 (16%) 40 (14%)
Urinary catheter 55 (17%) 41 (15%)
Other vascular device 26 (8%) 24 (9%)
Inserted by   
   • Junior doctor 232 (72%) 207 (74%)
   • Registered Nurse 67 (21%) 57 (20%)
   • Senior doctor 24 (7%) 16 (6%)
Where inserted   
   • Ward 216 (67%) 188 (67%)
   • Emergency department 74 (23%) 70 (25%)
   • Other 33 (10%) 22 (8%)
Current infection (site)   
   • Respiratory 97 (30%) 49 (18%)
   • Urinary 24 (7%) 19 (7%)
   • Wound 16 (5%) 15 (5%)
   • Other 29 (9%) 37 (13%)
   • >1 site 5 (2%) 4 (1%)
   N/A (none) 152 (47%) 156 (56%)
Risk of phlebitis (Tagar scale)   
   • Low 174 (54%) 144 (51%)
   • Medium 149 (46%) 136 (49%)
   • High 0 0